Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response. (Q43115873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Ming-Hsien Tsai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Keh-Ming Lin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Mei-Chun Hsiao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Winston W Shen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Mong-Liang Lu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hwa-Sheng Tang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Chun-Kai Fang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Shao-Chun Lu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Shu Chih Liu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Chun-Yu Chen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Yu-Li Liu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

537-546

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20350136%20AND%20SRC:MED&resulttype=core&format=json

Recurrence in major depressive disorder: a neurocognitive perspective

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Escitalopram therapy for major depression and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

The clinical pharmacokinetics of escitalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Accounting for ancestry: population substructure and genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Allelic distributions of CYP2D6 gene copy number variation in the Eastern Han Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Genetic polymorphism of CYP2D6 in Chinese subjects in Malaysia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real-time quantitative PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

A note on exact tests of Hardy-Weinberg equilibrium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Pharmacogenomics and individualized drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168

Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.168